SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-21-000018
Filing Date
2021-05-17
Accepted
2021-05-17 07:05:29
Documents
19
Period of Report
2021-05-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pirs-20210517.htm   iXBRL 8-K 36922
2 EX-99.1 a210517pr.htm EX-99.1 16582
6 GRAPHIC a210517pr001.jpg GRAPHIC 319414
7 GRAPHIC a210517pr002.jpg GRAPHIC 331735
8 GRAPHIC a210517pr003.jpg GRAPHIC 356822
9 GRAPHIC a210517pr004.jpg GRAPHIC 34393
10 GRAPHIC a210517pr005.jpg GRAPHIC 112496
11 GRAPHIC a210517pr006.jpg GRAPHIC 81385
  Complete submission text file 0001583648-21-000018.txt   1911493

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pirs-20210517.xsd EX-101.SCH 1950
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pirs-20210517_lab.xml EX-101.LAB 26285
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pirs-20210517_pre.xml EX-101.PRE 13763
12 EXTRACTED XBRL INSTANCE DOCUMENT pirs-20210517_htm.xml XML 11989
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 21927503
SIC: 2834 Pharmaceutical Preparations